Bolt Biotherapeutics, Inc.
BOLT
$3.68
-$0.18-4.71%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -28.74M | -29.58M | -33.38M | -42.68M | -50.71M |
| Total Depreciation and Amortization | 919.00K | 1.10M | 1.29M | 1.46M | 1.61M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 5.17M | 4.66M | 4.35M | 5.10M | 5.53M |
| Change in Net Operating Assets | -8.80M | -10.68M | -12.12M | -11.00M | -7.79M |
| Cash from Operations | -31.45M | -34.51M | -39.85M | -47.12M | -51.36M |
| Capital Expenditure | -85.00K | -72.00K | -72.00K | -72.00K | -41.00K |
| Sale of Property, Plant, and Equipment | 717.00K | 31.00K | 963.00K | 963.00K | 1.11M |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 34.02M | 37.72M | 43.41M | 54.57M | 53.64M |
| Cash from Investing | 34.65M | 37.67M | 44.30M | 55.46M | 54.71M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 30.00K | 25.00K | 19.00K | 43.00K | 43.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 30.00K | 25.00K | 19.00K | 43.00K | 43.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3.23M | 3.19M | 4.47M | 8.38M | 3.40M |